Yinong Young-Xu, ScD

  • 5Articles
  • 53.4KReads
  • 2013–2022Active
  • 24Collaborators
  • 792Citations

About

Yinong Young-Xu, ScD is affiliated with Mental Health Service, Veterans Affairs Medical Center, White River Junction, Vermont; Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire. Yinong Young-Xu has authored or co-authored 5 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2013 and 2022. Their work focuses on Posttraumatic Stress Disorder, Schizophrenia/Schizoaffective Disorders, Suicide, and Veterans and Military Issues.

Publications

JCP
Tools to Detect Suicide Risk
Meta-Analysis

Tools to Detect Suicide Risk

November 16, 2022

More than 20 instruments have been developed to assist in detecting suicide risk in adults. This systematic review used likelihood ratio analysis to determine the diagnostic accuracy of instruments...
, , , et al
JCP
Original Research

Medications for DSM-5 PTSD

October 13, 2020

This retrospective study explored whether 5 medications for PTSD with efficacy in meta-analyses of randomized controlled trials—fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine—are also effective in routine clinical practice.
, , , et al
JCP
Article

Comparing the Effectiveness of Medications for PTSD

September 18, 2018

When choosing among agents for treating PTSD, which one should you pick? Fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine have all shown efficacy. This large retrospective VA study compared the...
, , , et al
JCP
Original Research

Paliperidone Palmitate vs. Oral Atypical

October 26, 2016

Read a study comparing oral antipsychotics with paliperidone palmitate in a veteran population to evaluate health care resource utilization with each type of schizophrenia treatment.
, , , et al
JCP
Meta-Analysis

Meta-Analysis of the Efficacy of Treatments for Posttraumatic Stress Disorder

June 15, 2013

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe